Lista de obras -

A mouse model of melanoma driven by oncogenic KRAS.

artículo científico publicado en 2010

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

artículo científico publicado en 2012

Absence of microsatellite instability in mucinous carcinomas of the breast.

artículo científico publicado en 2010

Abstract 3917: EMSY amplification and overexpression is not associated with defective homologous recombination and does not predict sensitivity to cisplatin or PARP inhibitors

article by Paul Wilkerson et al published 15 April 2011 in Cancer Research

Abstract 4829: Massively parallel RNA sequencing analysis of micropapillary carcinomas of the breast

article by Rachael Natrajan et al published 15 April 2011 in Cancer Research

Abstract 5076: Integrative genomic and transcriptomic analysis of metaplastic carcinomas of the breast

article by Alan G. Mackay et al published 15 April 2012 in Cancer Research

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers

artículo científico publicado en 2011

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

artículo científico publicado en 2014

Chromogenic and fluorescent in situ hybridization in breast cancer

artículo científico publicado en 2007

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study

artículo científico publicado en 2010

DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes

artículo científico publicado en 2016

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer

artículo científico publicado en 2010

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

artículo científico publicado en 2010

Functional characterization of EMSY gene amplification in human cancers

artículo científico publicado en 2011

Functional characterization of the 19q12 amplicon in grade III breast cancers

artículo científico publicado en 2012

Functional viability profiles of breast cancer

artículo científico publicado en 2011

Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

artículo científico publicado en 2011

Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification

artículo científico publicado en 2017

Genetic characterization of breast cancer and implications for clinical management

artículo científico publicado en 2009

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

artículo científico publicado en 2008

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast

artículo científico publicado en 2010

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

artículo científico publicado en 2012

Genomic characterisation of acral melanoma cell lines

artículo científico publicado en 2012

Genomic profiling of histological special types of breast cancer

artículo científico publicado en 2013

Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research

artículo científico publicado en 2007

HER3 Is an Actionable Target in Advanced Prostate Cancer

artículo científico publicado en 2021

High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform

artículo científico publicado en 2011

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

artículo científico publicado en 2011

Immunophenotypic and genomic characterization of papillary carcinomas of the breast

artículo científico publicado en 2011

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

artículo científico publicado en 2021

Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?

artículo científico publicado en 2009

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer

artículo científico publicado en 2017

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

artículo científico publicado en 2005

Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma

artículo científico publicado en 2009

Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.

artículo científico publicado en 2009

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

artículo científico publicado en 2010

Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis

artículo científico publicado en 2012

Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type

artículo científico publicado en 2010

Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations

artículo científico publicado en 2013

Non-existence of caveolin-1 gene mutations in human breast cancer

artículo científico publicado en 2011

PI3K pathway dependencies in endometrioid endometrial cancer cell lines

artículo científico publicado en 2013

PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study

artículo científico publicado en 2010

PPM1D is a potential therapeutic target in ovarian clear cell carcinomas

artículo científico publicado en 2009

PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

artículo científico publicado en 2010

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity

scholarly article by Jorge Reis-Filho et al published 2005 in Journal of Pathology

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer

artículo científico publicado en 2016

RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors

artículo científico publicado en 2012

Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis

artículo científico publicado en 2018

The genomic landscape of oesophagogastric junctional adenocarcinoma

artículo científico publicado en 2013

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

artículo científico publicado en 2009

Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)

artículo científico publicado en 2018

Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization

artículo científico publicado en 2006

Whole genome sequencing of matched primary and metastatic acral melanomas

artículo científico publicado en 2011

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

artículo científico publicado en 2010

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast

artículo científico publicado en 2010

Lista de obras de

A mouse model of melanoma driven by oncogenic KRAS.

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

Absence of microsatellite instability in mucinous carcinomas of the breast.

Abstract 3917: EMSY amplification and overexpression is not associated with defective homologous recombination and does not predict sensitivity to cisplatin or PARP inhibitors

Abstract 4829: Massively parallel RNA sequencing analysis of micropapillary carcinomas of the breast

Abstract 5076: Integrative genomic and transcriptomic analysis of metaplastic carcinomas of the breast

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

Chromogenic and fluorescent in situ hybridization in breast cancer

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study

DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

Functional characterization of EMSY gene amplification in human cancers

Functional characterization of the 19q12 amplicon in grade III breast cancers

Functional viability profiles of breast cancer

Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification

Genetic characterization of breast cancer and implications for clinical management

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

Genomic characterisation of acral melanoma cell lines

Genomic profiling of histological special types of breast cancer

Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research

HER3 Is an Actionable Target in Advanced Prostate Cancer

High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Immunophenotypic and genomic characterization of papillary carcinomas of the breast

JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma

Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis

Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type

Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations

Non-existence of caveolin-1 gene mutations in human breast cancer

PI3K pathway dependencies in endometrioid endometrial cancer cell lines

PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study

PPM1D is a potential therapeutic target in ovarian clear cell carcinomas

PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer

RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors

Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis

The genomic landscape of oesophagogastric junctional adenocarcinoma

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)

Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization

Whole genome sequencing of matched primary and metastatic acral melanomas

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast